ISB Orders 615 Whole-Genome Sequences from Complete Genomics for Neurodegenerative Disease Study

"Partnering with Complete Genomics for our human sequencing needs has allowed us to focus on data analysis and interpretation while avoiding major capital expense, pipeline building, and technology development," said ISB President Leroy Hood in a statement.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.